Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
Glen Huang, Alex J. Kovalic, Christopher J. Graber
Emerging Infectious Diseases · 2020
doi:10.3201/eid2608.201160 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis of 10 studies. Severe illness was associated with lower lymphocyte and higher leukocyte counts. Using these markers for early identification of patients with severe disease may help healthcare providers prioritize the need to obtain therapy.
Abstract licence: CC BY
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.